LENZ Therapeutics, Inc. (LENZ)

LENZ Therapeutics, Inc. (LENZ) is a healthcare company (biotechnology) based in the United States. The share price is $3.60, down 5.76% on the day, which values the company at $113.11M. Price as of 17 Nov 2026, 17:43 UTC, from Yahoo Finance.

Key facts

Share price
$3.60−5.76% today
Market value
$113.11M
200-week average
$19.8282% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

LENZ Therapeutics, Inc. in more detail

LENZ trades at -3.0× next year's expected earnings, 9.2× sales. It sits 82% below its 200-week average of $19.82.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Heavy stock-based pay.

2 of the superinvestors tracked here hold LENZ, including Peter Kolchinsky (0.2% of the portfolio), Rob Citrone (0.1% of the portfolio).

Superinvestors holding LENZ

2 of the investors tracked here report a position in their latest 13F filing.

LENZ Therapeutics, Inc. (LENZ): questions and answers

What is LENZ Therapeutics, Inc.'s market cap?

LENZ Therapeutics, Inc. is valued at $113.11M at a share price of $3.60.

Is LENZ above its 200-week moving average?

No. LENZ is 81.8% below its 200-week average of $19.82. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is LENZ Therapeutics, Inc. growing?

Over the last three fiscal years LENZ Therapeutics, Inc.'s revenue grew 8.4% a year.

Does LENZ pay a dividend?

LENZ Therapeutics, Inc. does not currently pay a regular dividend.

Which famous investors own LENZ?

In their latest quarterly filings, Peter Kolchinsky (0.2% of the portfolio), Rob Citrone (0.1% of the portfolio) hold LENZ. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “LENZ Therapeutics, Inc. (LENZ) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/LENZ

Underlying data: Yahoo Finance; company filings with the SEC.